Currently lymphoedema therapy does not have a Medicare (MBS) number. When a chronic condition has no MBS number, it becomes invisible.
To support the ALA's submission for lymphoedema therapy to be allocated its own MBS (Medicare) number. ALA members and the broader lymphoedema community within Australia are being asked to join the letter writing campaign to Put lymphoedema on the list and write a letter to their local federal members.
There are benefits to having an MBS number for lymphoedema therapy including:
The Australasian Lymphology Association (ALA) is committed to promoting the development of lymphology in Australasia. The Association will strive to improve the management of those with, or at risk of developing lymphoedema and enhance communication between health professionals, educators, relevant authorities and government in regard to oedemas and lymphoedema.